$OFIX
Orthofix Medical Inc.

2018 Q2 Form 10-Q Financial Statement

#000156459018019507 Filed on August 06, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $111.5M $108.9M
YoY Change 2.39% 4.68%
Cost Of Revenue $22.84M $23.18M
YoY Change -1.48% 2.94%
Gross Profit $88.71M $85.77M
YoY Change 3.44% 5.16%
Gross Profit Margin 79.53% 78.73%
Selling, General & Admin $73.80M $70.90M
YoY Change 4.09% 10.8%
% of Gross Profit 83.19% 82.67%
Research & Development $7.891M $6.900M
YoY Change 14.36% 1.59%
% of Gross Profit 8.9% 8.05%
Depreciation & Amortization $4.500M $5.300M
YoY Change -15.09% 3.92%
% of Gross Profit 5.07% 6.18%
Operating Expenses $82.80M $77.77M
YoY Change 6.47% -7.7%
Operating Profit $5.915M $7.998M
YoY Change -26.04% -396.77%
Interest Expense -$300.0K $100.0K
YoY Change -400.0% -200.0%
% of Operating Profit -5.07% 1.25%
Other Income/Expense, Net -$4.800M $600.0K
YoY Change -900.0% 308.16%
Pretax Income $2.021M $8.700M
YoY Change -76.77% -426.94%
Income Tax $1.100M $3.924M
% Of Pretax Income 54.43% 45.1%
Net Earnings $925.0K $3.853M
YoY Change -75.99% -151.76%
Net Earnings / Revenue 0.83% 3.54%
Basic Earnings Per Share $0.05 $0.21
Diluted Earnings Per Share $0.05 $0.21
COMMON SHARES
Basic Shares Outstanding 18.41M 18.05M
Diluted Shares Outstanding 18.84M 18.34M

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.70M $44.30M
YoY Change 3.16% 9.38%
Cash & Equivalents $45.69M $44.33M
Short-Term Investments
Other Short-Term Assets $35.60M $17.20M
YoY Change 106.98% -13.13%
Inventory $81.70M $75.90M
Prepaid Expenses
Receivables $74.40M $61.20M
Other Receivables $0.00 $0.00
Total Short-Term Assets $237.4M $198.6M
YoY Change 19.54% 11.58%
LONG-TERM ASSETS
Property, Plant & Equipment $44.40M $46.70M
YoY Change -4.93% -11.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $36.50M $59.30M
YoY Change -38.45% 261.12%
Total Long-Term Assets $204.4M $169.1M
YoY Change 20.88% -9.45%
TOTAL ASSETS
Total Short-Term Assets $237.4M $198.6M
Total Long-Term Assets $204.4M $169.1M
Total Assets $441.8M $367.7M
YoY Change 20.15% 0.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.50M $14.20M
YoY Change 2.11% 3.65%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $63.90M $65.10M
YoY Change -1.84% -15.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $58.00M $25.60M
YoY Change 126.56% -12.65%
Total Long-Term Liabilities $58.00M $25.60M
YoY Change 126.56% -12.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $63.90M $65.10M
Total Long-Term Liabilities $58.00M $25.60M
Total Liabilities $121.9M $90.70M
YoY Change 34.4% -14.84%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $319.8M $276.9M
YoY Change
Total Liabilities & Shareholders Equity $441.8M $367.7M
YoY Change 20.15% 0.81%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income $925.0K $3.853M
YoY Change -75.99% -151.76%
Depreciation, Depletion And Amortization $4.500M $5.300M
YoY Change -15.09% 3.92%
Cash From Operating Activities $16.60M $20.60M
YoY Change -19.42% 22.62%
INVESTING ACTIVITIES
Capital Expenditures -$3.100M -$4.700M
YoY Change -34.04% 17.5%
Acquisitions
YoY Change
Other Investing Activities -$43.70M $0.00
YoY Change -100.0%
Cash From Investing Activities -$46.80M -$4.700M
YoY Change 895.74% -28.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 600.0K
YoY Change -100.0% -106.52%
NET CHANGE
Cash From Operating Activities 16.60M 20.60M
Cash From Investing Activities -46.80M -4.700M
Cash From Financing Activities 0.000 600.0K
Net Change In Cash -30.20M 16.50M
YoY Change -283.03% 1550.0%
FREE CASH FLOW
Cash From Operating Activities $16.60M $20.60M
Capital Expenditures -$3.100M -$4.700M
Free Cash Flow $19.70M $25.30M
YoY Change -22.13% 21.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18288050
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18015308
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-3220000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1278000
CY2018Q2 ofix Percentage Of Reported Increase Decrease
PercentageOfReportedIncreaseDecrease
0.024
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
51529000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
7024000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
7998000
us-gaap Operating Income Loss
OperatingIncomeLoss
14897000
CY2018Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-251000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111547000
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108942000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
220256000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22268000
us-gaap Net Income Loss
NetIncomeLoss
6151000
CY2017Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
76000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53941000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
6162000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-3000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-1827000
CY2017Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-418000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
8000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-599000
CY2018Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-8000
CY2017Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-882000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-11000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-1228000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
925000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
3853000
us-gaap Net Income Loss
NetIncomeLoss
1199000
CY2018Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.05
CY2017Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.26
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.33
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.13
CY2017Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.05
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2018Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.05
CY2017Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.26
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.32
CY2017Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.05
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.06
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
432000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-474000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51549000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8119000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5416000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5282000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1375000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2851000
ofix Payment Of Debt Issuance Costs And Other Financing Activities
PaymentOfDebtIssuanceCostsAndOtherFinancingActivities
356000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3685000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2431000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-639000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
719000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8923000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10447000
ofix Amortization Of Debt Costs And Other Assets
AmortizationOfDebtCostsAndOtherAssets
592000
ofix Amortization Of Debt Costs And Other Assets
AmortizationOfDebtCostsAndOtherAssets
719000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-360000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
820000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
724000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4284000
us-gaap Share Based Compensation
ShareBasedCompensation
9131000
us-gaap Share Based Compensation
ShareBasedCompensation
5492000
us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
5585000
ofix Gain On Valuation Of Equity Securities
GainOnValuationOfEquitySecurities
1399000
ofix Revaluation Of Contingent Consideration
RevaluationOfContingentConsideration
1109000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-847000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-572000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
363000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3787000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5251000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11119000
ofix Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-71000
ofix Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-2199000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3847000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-950000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-14612000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-19407000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-814000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
696000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13032000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4642000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
43749000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5782000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7035000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
870000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1558000
ofix Asset Acquisition And Other Investments
AssetAcquisitionAndOtherInvestments
1148000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-35471000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9611000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
81157000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
45686000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44330000
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
1181000
CY2018Q2 ofix Revenue From Product Sales
RevenueFromProductSales
97453000
CY2017Q2 ofix Revenue From Product Sales
RevenueFromProductSales
93908000
ofix Revenue From Product Sales
RevenueFromProductSales
192342000
ofix Noncash Or Part Noncash Acquisition Contingent Consideration Recognized At Date
NoncashOrPartNoncashAcquisitionContingentConsiderationRecognizedAtDate
-25491000
us-gaap Number Of Reporting Units
NumberOfReportingUnits
4
ofix Prepaid Income Taxes
PrepaidIncomeTaxes
8600000
ofix Number Of Assets Transferred
NumberOfAssetsTransferred
2
CY2018Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
9210000
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6067000
CY2018Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
13502000
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12487000
CY2018Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
59018000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
60441000
CY2017Q4 ofix Deferred Cost Of Sales Net Of Reserves
DeferredCostOfSalesNetOfReserves
2335000
CY2018Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
9000000
CY2018Q2 ofix Discontinued Operations Obligated To Make Final Payment To Insurer
DiscontinuedOperationsObligatedToMakeFinalPaymentToInsurer
1700000
CY2018Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3300000
CY2018Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2800000
us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
1482000
CY2018Q2 ofix Marketing Service Fees
MarketingServiceFees
14094000
CY2017Q2 ofix Marketing Service Fees
MarketingServiceFees
15034000
ofix Marketing Service Fees
MarketingServiceFees
27914000
ofix Marketing Service Fees
MarketingServiceFees
29371000
ofix Percentage Of Reported Increase Decrease
PercentageOfReportedIncreaseDecrease
0.041
ofix Revenue From Product Sales
RevenueFromProductSales
182309000
CY2018Q2 ofix Non Gaap Net Margin
NonGAAPNetMargin
37183000
CY2017Q2 ofix Non Gaap Net Margin
NonGAAPNetMargin
35294000
ofix Non Gaap Net Margin
NonGAAPNetMargin
71477000
ofix Non Gaap Net Margin
NonGAAPNetMargin
66919000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5215000
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2676000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9131000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5492000
CY2018Q2 ofix Stock Shares Issued Net Of Shares For Tax Withholdings
StockSharesIssuedNetOfSharesForTaxWithholdings
80444
CY2017Q2 ofix Stock Shares Issued Net Of Shares For Tax Withholdings
StockSharesIssuedNetOfSharesForTaxWithholdings
76596
ofix Stock Shares Issued Net Of Shares For Tax Withholdings
StockSharesIssuedNetOfSharesForTaxWithholdings
206955
ofix Stock Shares Issued Net Of Shares For Tax Withholdings
StockSharesIssuedNetOfSharesForTaxWithholdings
291275
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.538
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.453
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.512
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.764
CY2017Q4 ofix Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
8300000
CY2018Q2 ofix Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
-500000
ofix Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
-500000
us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
Upon the effectiveness of the Domestication, each common share of Orthofix International N.V. was automatically converted into one share of common stock of Orthofix Medical Inc. The Company’s common stock continues to be traded on the Nasdaq Global Select Market under the symbol “OFIX.”

Files In Submission

Name View Source Status
0001564590-18-019507-index-headers.html Edgar Link pending
0001564590-18-019507-index.html Edgar Link pending
0001564590-18-019507.txt Edgar Link pending
0001564590-18-019507-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
goqer25hngl3000001.jpg Edgar Link pending
ofix-10q_20180630.htm Edgar Link pending
ofix-20180630.xml Edgar Link completed
ofix-20180630.xsd Edgar Link pending
ofix-20180630_cal.xml Edgar Link unprocessable
ofix-20180630_def.xml Edgar Link unprocessable
ofix-20180630_lab.xml Edgar Link unprocessable
ofix-20180630_pre.xml Edgar Link unprocessable
ofix-ex311_6.htm Edgar Link pending
ofix-ex312_9.htm Edgar Link pending
ofix-ex321_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending